Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia

Thomas Trimarchi1, Erhan Bilal2, Panagiotis Ntziachristos1

  • 1Howard Hughes Medical Institute, Laura and Isaac Perlmutter Cancer Center, and Helen L. and Martin S. Kimmel Center for Stem Cell Biology, NYU School of Medicine, 550 First Avenue, New York, NY 10016, USA; Department of Pathology, NYU School of Medicine, 550 First Avenue, New York, NY 10016, USA.

Cell
|August 2, 2014
PubMed

Insights

Long noncoding RNAs (lncRNAs) are downstream targets of oncogenic Notch1 signaling in T-cell acute lymphoblastic leukemia (T-ALL). A specific lncRNA, LUNAR1, drives T-ALL growth by enhancing IGF1R signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Notch signaling is crucial in development and frequently altered in human cancers.
  • Aberrant Notch1 signaling drives T-cell acute lymphoblastic leukemia (T-ALL) pathogenesis.
  • The role of long noncoding RNAs (lncRNAs) as downstream targets of Notch signaling in T-ALL is not well understood.

Purpose of the Study:

  • To investigate lncRNA genes as downstream targets of oncogenic Notch1 in T-ALL.
  • To identify novel T-ALL-specific lncRNAs regulated by Notch1.
  • To determine the functional role of Notch-regulated lncRNAs in T-ALL growth.

Main Methods:

  • Integration of transcriptome profiling with chromatin state mapping.
  • Analysis of Notch1/Rpbjκ direct transcriptional targets.
  • In vitro and in vivo functional assays to assess T-ALL growth.

Main Results:

  • Discovery of numerous T-ALL-specific lncRNA genes.
  • Identification of lncRNAs directly controlled by the Notch1/Rpbjκ complex.
  • Demonstration that LUNAR1, a Notch-regulated lncRNA, promotes T-ALL proliferation by upregulating IGF1R mRNA and sustaining IGF1 signaling.

Conclusions:

  • lncRNAs are significant downstream targets of the Notch signaling pathway in T-ALL.
  • Notch-regulated lncRNAs, such as LUNAR1, are critical regulators of the oncogenic state in T-ALL.
  • Targeting lncRNAs may offer novel therapeutic strategies for T-ALL.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K